SOLID TUMORS
Clinical trials for SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMORS trials appear
Sign up with your email to follow new studies for SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug ATB-320 enters first human tests for tough cancers
Disease control Not yet recruitingThis early-stage trial tests the safety of a new drug called ATB-320 in 24 adults with advanced solid tumors that have spread or are no longer responding to standard treatments. The main goal is to find the highest safe dose and identify any side effects. Participants will receiv…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Autotelicbio • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests a new gene therapy that trains a patient's own immune cells (T cells) to recognize and attack cancer cells carrying a protein called CD70. It is for people with lymphoma, myeloma, or certain solid tumors (like kidney cancer or sarcoma) that have retur…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Engineered immune cells take aim at deadliest lung cancer
Disease control Not yet recruitingThis early-phase study tests a new treatment for people with extensive-stage small cell lung cancer or similar neuroendocrine cancers that did not respond to or came back after standard therapy. The treatment uses the patient's own immune cells (T cells) that are modified in a la…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC
-
New targeted drug KIVU-305 enters first human tests for Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests a new drug called KIVU-305 in people with advanced solid tumors that have stopped responding to standard treatments. The drug is designed to target and attack cancer cells while sparing healthy ones. The main goal is to find the safest dose and check …
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Kivu Bioscience Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New theranostic approach targets brain metastases in solid tumors
Disease control Not yet recruitingThis study tests whether a special radioactive drug can find and treat solid tumors that have spread to the brain. About 10 adults with HER2-positive breast cancer and active brain metastases will receive the drug. The goal is to see if the drug targets the brain tumors and shrin…
Matched conditions: SOLID TUMORS
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Chill out cancer? new study combines cold therapy with immunotherapy
Disease control Not yet recruitingThis early-phase study tests whether spending time in a cool room (around 18°C) can make standard immunotherapy work better for people with solid tumors. About 24 participants will receive the cold exposure alongside their usual PD-1/PD-L1 inhibitor treatment. The main goals are …
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
New dual-target PET probe aims to sharpen cancer imaging
Diagnosis Not yet recruitingThis study tests a new radioactive imaging agent called 68Ga-B6FA-01, designed to make PET/CT scans more accurate for detecting and staging solid tumors. The probe targets two different markers found on cancer cells and their surroundings, which may improve image clarity. About 1…
Matched conditions: SOLID TUMORS
Sponsor: Zhongnan Hospital • Aim: Diagnosis
Last updated Apr 29, 2026 15:05 UTC